Signal Advisors Wealth’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Signal Advisors Wealth’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,600	Closed	-$3.6K	–	675
2026 Q1	$3.6K	Buy	+14,600	New	+$5.81K	﹤0.01%	579

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Signal Advisors Wealth's SGMO Position: Q2 2026 in Review

Signal Advisors Wealth sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 14,600 shares — an estimated $3.6K sold.

Signal Advisors Wealth first reported a position in SGMO in Q1 2026 and held it in 1 quarter. The position peaked at $3.6K in Q1 2026. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Signal Advisors Wealth reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Signal Advisors Wealth sold 14,600 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $3.6K.
Signal Advisors Wealth first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and held it in 1 quarter.
Signal Advisors Wealth's SANGAMO THERAPEUTICS INC position peaked at $3.6K in Q1 2026.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.